Accelerate Diagnostics DSO Ratio 2011-2026 | AXDX

Annual DSO Ratio Accelerate Diagnostics

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
291	211	78	126	120	170	50.4	191	233	184	1.16 K	194

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.16 K	50.4	251

Quarterly DSO Ratio Accelerate Diagnostics

2024-Q3	2024-Q2	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
66.2	75	-	69.3	74.5	78.6	-	82.1	59.7	68.4	62.6	64	66.7	63.9	45.5	39.4	66.6	93	84.7	129	163	132	93.2	125	100	217	83.8	214	254	170	79.5	129	155	31.1	319	76.4	370	505	90.1	445	548	332	182	168	313	2.25 K	8.37 K	13.6 K	3.07 K	11.6 K	306	306	69.8	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
13.6 K	31.1	905

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
ICON Public Limited Company ICLR	68.5	$ 98.33	0.9 %	$ 8.11 B	Irlanda
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
Aspira Women's Health AWH	50.7	-	-6.19 %	$ 10.5 M	USA
Charles River Laboratories International CRL	65	$ 155.46	1.83 %	$ 7.71 B	USA
Bioventus BVS	82.1	$ 8.62	0.23 %	$ 574 M	USA
DexCom DXCM	87	$ 64.24	-1.56 %	$ 25.1 B	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
Castle Biosciences CSTL	49.2	$ 25.56	0.95 %	$ 710 M	USA
CareDx, Inc CDNA	51.5	$ 17.01	3.4 %	$ 906 M	USA
Exact Sciences Corporation EXAS	30.8	$ 103.57	0.29 %	$ 19.5 B	USA
Guardant Health GH	46.1	$ 85.49	1.75 %	$ 10.7 B	USA
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
Fulgent Genetics FLGT	77.4	$ 14.77	0.61 %	$ 447 M	USA
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Biodesix BDSX	41.7	$ 17.88	-6.63 %	$ 2.32 B	USA
Anixa Biosciences ANIX	275	$ 2.83	-1.05 %	$ 91.8 K	USA
Danaher Corporation DHR	55.3	$ 187.32	0.57 %	$ 134 B	USA
IQVIA Holdings IQV	73.9	$ 164.72	1.1 %	$ 28.3 B	USA
Biocept BIOC	112	-	-13.05 %	$ 7.29 M	USA
Heska Corporation HSKA	40.8	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	101	-	-20.0 %	$ 1.06 M	USA
Illumina ILMN	61.3	$ 118.94	2.92 %	$ 18.9 B	USA
Quest Diagnostics Incorporated DGX	44.9	$ 199.7	-0.46 %	$ 22.2 B	USA
QIAGEN N.V. QGEN	30.8	-	-	$ 10.6 B	Niderland
Agilent Technologies A	63.8	$ 111.51	-0.06 %	$ 33.9 B	USA
BioNano Genomics BNGO	83.4	$ 1.11	-0.89 %	$ 1.41 M	USA
DarioHealth Corp. DRIO	85.8	$ 9.0	-0.99 %	$ 255 M	Israel
Neogen Corporation NEOG	66.6	$ 9.09	-2.78 %	$ 1.97 B	USA
National Research Corporation NRC	29.4	$ 16.52	0.12 %	$ 370 M	USA
Chembio Diagnostics CEMI	66.3	-	0.22 %	$ 16.8 M	USA
Pacific Biosciences of California PACB	71.8	$ 1.33	4.72 %	$ 399 M	USA
Co-Diagnostics CODX	101	-	-	$ 79.8 M	USA
Medpace Holdings MEDP	50.4	$ 450.41	1.48 %	$ 13 B	USA
DermTech DMTK	80.6	-	-11.32 %	$ 2.94 M	USA
Mettler-Toledo International MTD	66.4	$ 1 173.74	0.49 %	$ 24.2 B	Schweiz
Personalis PSNL	55.8	$ 6.72	1.97 %	$ 398 M	USA
NeoGenomics NEO	77.7	$ 7.88	-1.25 %	$ 1.01 B	USA
Enzo Biochem ENZ	50.3	-	-8.98 %	$ 14.8 K	USA
Natera NTRA	81.5	$ 187.85	-1.29 %	$ 18.5 B	USA
Sotera Health Company SHC	43.9	$ 13.42	0.71 %	$ 3.81 B	USA
Invitae Corporation NVTA	242	-	-	$ 21.2 M	USA
OPKO Health OPK	240	$ 1.19	2.59 %	$ 826 M	USA